Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
864.90
+27.33 (+3.26%)
Official Closing Price
Updated: 7:00 PM EDT, Mar 24, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
On Sale Now: 20 Blue Chip Stocks to Buy
March 13, 2025
These 20 blue chip companies are the largest traded on U.S. exchanges.
Via
The Motley Fool
Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped
March 12, 2025
Ignore the noise in GLP-1 stocks. Find the best value instead.
Via
The Motley Fool
Roche Inks 'The Largest Obesity Deal To Date' With Zealand Pharma At $5.3 Billion
March 12, 2025
The company is looking to test a combination of the drug it acquired from Carmot Therapeutics and a amylin-based drug.
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
March 11, 2025
Via
Benzinga
Unpacking the Latest Options Trading Trends in Eli Lilly
March 11, 2025
Via
Benzinga
Why Eli Lilly Stock Flopped Today
March 10, 2025
Via
The Motley Fool
Merck Injects $1 Billion To Expand Vaccine Production In US
March 11, 2025
Merck unveils a $1 billion vaccine manufacturing facility in Durham, North Carolina, expanding its U.S. production and research investments.
Via
Benzinga
Why Hims & Hers Health Stock Just Popped
March 11, 2025
Via
The Motley Fool
Eli Lilly-Incyte Partnered FDA-Approved Drug Shows Encouraging Efficacy In Adolescent Patients With Patchy Hair Loss
March 11, 2025
Eli Lilly and Incyte's baricitinib showed significant hair regrowth in adolescents with severe alopecia areata, with results comparable to adults at 52 weeks.
Via
Benzinga
Hims & Hers Stock Is Down 50% From Its High, but Is This a Buying Opportunity?
March 11, 2025
Shutting down an acquisition caught investor attention, but there's more to the story.
Via
The Motley Fool
Is Eli Lilly Stock a Buy?
March 11, 2025
Via
The Motley Fool
The Reality of Trump's Tariffs
March 10, 2025
Via
The Motley Fool
Topics
Government
Exposures
Political
The State of Weight Loss Drugs
March 10, 2025
Via
The Motley Fool
Amgen And Kyowa Kirin's Rocatinlimab Reduces Eczema Severity In Phase 3 Study
March 10, 2025
Amgen and Kyowa Kirin's rocatinlimab showed strong efficacy in Phase 3 trials for atopic dermatitis, achieving key endpoints in IGNITE and SHUTTLE studies.
Via
Benzinga
Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
March 10, 2025
Novo Nordisk slashed prices on its GLP-1 obesity drugs as it launches NovoCare to gain compounded GLP-1 users as the compounding labs face deadlines to cease.
Via
MarketBeat
Exposures
Product Safety
3 Cold Stocks That Can Bounce Back This Week
March 10, 2025
These three stocks tumbled by at least 20% last week, but they may not be down for long.
Via
The Motley Fool
Novo Nordisk Dives 8%. Why Eli Lilly Now Has The Upper Hand.
March 10, 2025
Novo Nordisk's experimental obesity drug failed to top Eli Lilly's Zepbound. But there's something else that rattled investors.
Via
Investor's Business Daily
3 Magnificent Growth Stocks to Buy in March
March 08, 2025
Via
The Motley Fool
MarketBeat Week in Review – 03/03 - 03/07
March 08, 2025
Stocks had another down week despite a mostly benign jobs report; and with the latest reads on inflation coming next week the uncertainty may continue
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Discover which S&P500 stocks are making waves on Friday.
March 07, 2025
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Friday.
Via
Chartmill
Eli Lilly's Single Monthly Maintenance Shot Of Eczema Drug Shows Completely Clear Skin At 3 Years In 50% Of Trial Patients
March 07, 2025
Eli Lilly's Ebglyss showed sustained eczema relief, with 50% achieving full skin clearance and 87% maintaining near-clear skin over three years.
Via
Benzinga
Eli Lilly Direct-To-Consumer Push Shouldn't Worry Distributors: JPMorgan
March 07, 2025
Teladoc Health is integrating LillyDirect into its Chronic Care Weight Management program, potentially boosting enrollments.
Via
Benzinga
Weight Loss Drugs Soar While Global Obesity Rates Climb, To Hit 50% Of Adults By 2050 Says New Report
March 06, 2025
A global study shows obesity rates predicted to climb. Are weight loss drugs not doing enough or not available in enough countries?
Via
Benzinga
3 Super Growth Stocks: 2 To Buy – 1 To Sell
March 06, 2025
PLTR, LLY and NVDA are probably three of the hottest, most popular stocks on the planet today.
Via
Talk Markets
Topics
Stocks / Equities
Alzheimer's Drugs From Eli Lilly And Biogen Still Deemed Too Costly For NHS Funding
March 06, 2025
NICE has upheld its decision not to recommend Alzheimer's treatments donanemab and lecanemab for NHS use, citing high costs and limited benefit. Stakeholders can submit feedback until March 27, 2025,...
Via
Benzinga
Teladoc Health Partners With Eli Liily's LillyDirect to Expand Access to Zepbound For Weight Loss
March 06, 2025
Teladoc Health teams up with Eli Lilly's LillyDirect to improve Zepbound access, offering direct home delivery and comprehensive obesity care support.
Via
Benzinga
Eli Lilly Pours $27B Into U.S. Growth—What It Means for Investors
March 06, 2025
Pharma giant Eli Lilly announced plans to make a massive investment in the United States. What does this and another big announcement mean for Lilly?
Via
MarketBeat
Topics
Bonds
Economy
Government
Exposures
Debt Markets
Economy
Interest Rates
3 Monster Stocks to Hold for the Next 10 Years
March 06, 2025
Via
The Motley Fool
Stock Market Sell-Off: The 9 Best Stocks to Buy Now in March (2025)
March 06, 2025
Via
The Motley Fool
Amgen Challenges Novo Nordisk's Ozempic And Eli Lilly's Zepbound As Its Monthly Weight Loss Drug MariTide Enters Two Late-Stage Trials
March 06, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.